To discuss SARS-CoV-2 collaborations involving primary respiratory organoids, email us at firstname.lastname@example.org
Precision Medicine - Made Possible
Developing drugs for indications with high unmet need through patient-derived disease models and artificial intelligence
Precision medicine–tailoring drug treatment
to specific patient populations–holds enormous potential for the future of healthcare. Here at PBA, we conduct phenotypic drug discovery and development using patient-derived disease models and AI to advance treatments for targeted patient populations.
We believe that precision medicine can address the complexities of disease and biological interactions on the whole-genome level.
PBA is developing drugs for multiple indications, including cystic fibrosis, COPD, celiac disease and chronic rhinosinusitis.